Study of NT-501 Encapsulated Cell Therapy for Glaucoma Neuroprotection and Vision Restoration
Study of NT-501 Encapsulated Cell Therapy for Glaucoma Neuroprotection and Vision Restoration
Active, not recruiting · NCT02862938 · Registry updated 2025-11-04Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Study of NT-501 Encapsulated Cell Therapy for Glaucoma Neuroprotection and Vision Restoration | eye disorder, glaucoma, ocular hypertension | Active, not recruiting | Phase 2 | 2025-11-04 | NCT02862938 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Stanford University | 620 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Byers Eye Institute at Stanford University | Palo Alto | United States | 11 |